Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.27B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.23B |
| 3 |
SPDR Gold Trust
GLD
|
+$710M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$662M |
| 5 |
Abbott
ABT
|
+$459M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.33B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$932M |
| 3 |
TransDigm Group
TDG
|
+$833M |
| 4 |
MPLX
MPLX
|
+$616M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$593M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.4% |
| 2 | Financials | 10.07% |
| 3 | Consumer Discretionary | 8.39% |
| 4 | Healthcare | 7.69% |
| 5 | Communication Services | 6.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GAP
776
The Gap Inc
GAP
$7.23B
| $65.6M | 0.02% |
2,102,762
+553,283
| +36% | +$18.1M |
|
777
Teva Pharmaceuticals
TEVA
$40.8B
| $65.5M | 0.02% |
3,830,049
-2,593,449
| -40% | -$50.6M |
|
778
Pacer Trendpilot US Mid Cap ETF
PTMC
$392M
| $65.3M | 0.02% |
2,117,301
+177,124
| +9% | +$5.56M |
|
|
BLUE
779
DELISTED
bluebird bio
BLUE
| $65.2M | 0.02% |
29,489
+18,269
| +163% | +$46.5M |
|
|
UN
780
DELISTED
Unilever NV New York Registry Shares
UN
| $65.2M | 0.02% |
1,155,782
-95,725
| -8% | -$5.26M |
|
781
Service Corp International
SCI
$11.7B
| $65.2M | 0.02% |
1,726,291
+49,691
| +3% | +$1.91M |
|
782
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.32B
| $64.9M | 0.02% |
773,723
-78,145
| -9% | -$6.61M |
|
|
NFJ
783
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.41B
| $64.6M | 0.02% |
5,086,168
-405,603
| -7% | -$5.33M |
|
|
ENLK
784
DELISTED
EnLink Midstream Partners, LP
ENLK
| $64.6M | 0.02% |
4,726,479
-1,019,793
| -18% | -$16.2M |
|
785
Darden Restaurants
DRI
$23.3B
| $64.5M | 0.02% |
756,944
-173,965
| -19% | -$16.5M |
|
786
O'Reilly Automotive
ORLY
$72.9B
| $64.5M | 0.02% |
3,912,090
-1,844,040
| -32% | -$31.2M |
|
787
Jack Henry & Associates
JKHY
$10.9B
| $64.4M | 0.02% |
532,661
-24,813
| -4% | -$3.02M |
|
788
Capri Holdings
CPRI
$1.83B
| $64.4M | 0.02% |
1,036,780
-52,158
| -5% | -$3.32M |
|
789
iShares MSCI USA Value Factor ETF
VLUE
$9.17B
| $64.1M | 0.02% |
780,963
+251,091
| +47% | +$21.4M |
|
790
ON Semiconductor
ON
$31.8B
| $63.9M | 0.02% |
2,611,001
-734,718
| -22% | -$17.7M |
|
791
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$16.7B
| $63.7M | 0.02% |
1,578,881
+108,447
| +7% | +$4.56M |
|
792
Invesco FTSE RAFI US 1000 ETF
PRF
$9.79B
| $63.3M | 0.02% |
2,871,245
-295,955
| -9% | -$6.77M |
|
793
Xylem
XYL
$27.3B
| $63.2M | 0.02% |
821,637
-81,693
| -9% | -$6.04M |
|
794
Gaming and Leisure Properties
GLPI
$12.7B
| $62.6M | 0.02% |
1,871,004
+14,106
| +0.8% | +$489K |
|
795
Cognex
CGNX
$10.9B
| $62.4M | 0.02% |
1,200,955
+328,366
| +38% | +$19.4M |
|
796
Editas Medicine
EDIT
$396M
| $62.4M | 0.02% |
1,883,262
+1,261,243
| +203% | +$44.9M |
|
797
DTE Energy
DTE
$29.5B
| $62.3M | 0.02% |
701,094
-37,263
| -5% | -$3.27M |
|
798
iShares Core MSCI Europe ETF
IEUR
$8.97B
| $62.1M | 0.02% |
1,250,092
+94,964
| +8% | +$4.84M |
|
|
VTA
799
DELISTED
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
| $61.9M | 0.02% |
5,280,833
-30,993
| -0.6% | -$364K |
|
800
L3Harris
LHX
$51.6B
| $61.8M | 0.02% |
383,114
-484,538
| -56% | -$74M |
|
Similar funds
Morgan Stanley's Q1 2018 Portfolio in Review
As of Q1 2018, Morgan Stanley held 6,930 positions worth $360B, down 1.4% from $365B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q1 2018: portfolio turnover was 4.7%. Morgan Stanley opened 170 new positions and exited 155, leaving the 6,930-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q1 2018 buy was Nutrien: 1,554,481 shares worth $73.5M.
- Morgan Stanley added most to iShares Russell 2000 ETF in Q1 2018, an estimated $1.27B increase.
- Morgan Stanley's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.33B.
- Morgan Stanley fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $86M.
- Morgan Stanley's ten largest holdings make up 14% of its $360B portfolio in Q1 2018.
- Morgan Stanley opened 170 new positions and closed 155 in Q1 2018.
- Morgan Stanley's portfolio value fell 1.4% quarter-over-quarter to $360B.
Based on Morgan Stanley's 13F filing for Q1 2018, filed 14 May 2018.